home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Validation for the New FDA Inspections

 
  February 26, 2018  
     
 
Netzealous LLC DBA - Compliance4All, Online
2018-04-05


Overview:
How to conduct a software validation program that will satisfy FDA requirements and produce a safe product.

Why should you Attend:
There are additional requirements,analyses and tests that FDA feels are necessary to prevent user injuries. These requirements were developed after analysis by the FDA of many recalled medical devices. In this webinar you will learn the requirements in addition to functional tests that are required to produce a validated software product. 

Areas Covered in the Session:
Software Validation more than Testing
Requirements Traceability
Risk Analysis
Unit,Integration and System Testing
Algorithm Validation
Challenges to the Software
Configuration Management

Who Will Benefit:
Engineer
Engineer Management
Software Engineer
Programmer
Quality Assurance
Regulatory


Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
 
 
Organized by: Event Manager
Invited Speakers:
Speaker Profile:
Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA.
 
Deadline for Abstracts: 2018-04-04
 
Registration: http://www.compliance4all.com/control/w_product/~product_id=501817LIVE?channel=molgen_Apr_2018_SEO
E-mail: support@compliance4All.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.